Summary
Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalone software. Fabric’s opal software offers opal clinical, opal research, opal in silico panels, and opal clinical trials. Omicia’s opal clinical software interprets and reports platform for clinical testing on targeted gene panels, exomes and whole genomes. The company’s VAAST is a disease gene finder and variant scoring algorithm used in academic and clinical institutions. It serves commercial clinical laboratories, country sequencing programs, hospital core labs, and research institutions. Omicia is headquartered in Oakland, California, the US.
Fabric Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fabric Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fabric Genomics Inc, Medical Devices Deals, 2011 to YTD 2017 8
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Omicia Raises US$7 Million In Series A Financing Round 10
Partnerships 11
Fabric Genomics Enters into Agreement with ITTM 11
Real Time Genomics Enters Into Technology Integration Agreement With Omicia 11
Spiral Genetics Enters Into Agreement With Omicia To Analyze Genomes And Prioritize Disease-Causing Variants 12
Licensing Agreements 13
Omicia Enters Into Licensing Agreement With University of Utah Health Sciences 13
Fabric Genomics Inc - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Mar 03, 2016: Omicia Announces Appointment of Matt Tindall as Chief Executive Officer 18
Product News 19
Mar 09, 2016: Omicia Implements ACMG Variant Scoring and Classification Guidelines to Drive Clinical NGS Report Consistency and Throughput 19
Other Significant Developments 20
Mar 21, 2017: Omicia Rebrands as Fabric Genomics; Launches New End-to-End Computational Genomics Platform 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21List of Tables
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 1
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 1
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fabric Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fabric Genomics Inc, Medical Devices Deals, 2011 to YTD 2017 8
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Omicia Raises US$7 Million In Series A Financing Round 10
Fabric Genomics Enters into Agreement with ITTM 11
Real Time Genomics Enters Into Technology Integration Agreement With Omicia 11
Spiral Genetics Enters Into Agreement With Omicia To Analyze Genomes And Prioritize Disease-Causing Variants 12
Omicia Enters Into Licensing Agreement With University of Utah Health Sciences 13
Fabric Genomics Inc, Key Competitors 15
Fabric Genomics Inc, Key Employees 16
Fabric Genomics Inc, Subsidiaries 17List of Figures
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Fabric Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Fabric Genomics Inc, Medical Devices Deals, 2011 to YTD 2017 8
